A Study of MZE782 in Adults With PKU

NCT07694440 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria (PKU)

Interventions

DRUG: MZE782
OTHER: Placebo
DRUG: MZE782

Sponsor

Maze Therapeutics